share_log

NeoGenomics To Present Four Studies At AMP 2024 Showcasing CtDNA And NGS Advancements For Cancer Diagnostics And Personalized Treatment

NeoGenomics To Present Four Studies At AMP 2024 Showcasing CtDNA And NGS Advancements For Cancer Diagnostics And Personalized Treatment

neogenomics將在2024年AMP會議上展示四項研究,展示用於癌症診斷和個性化治療的CtDNA和NGS進展。
Benzinga ·  11/19 21:19

Highlights Include Solid Tumor Profiling, Liquid Biopsy Sensitivity, And HPV Subtyping Innovations

亮點包括實體腫瘤分析、液體活檢靈敏度和HPV分型創新

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論